Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Xbrane Biopharma AB

Closing information (x1000 NOK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 241,840 Less Arrow 54,502 Less Arrow 0
Financial expenses 18,804 Less Arrow 2,172 More Arrow 2,578
Earnings before taxes -326,225 More Arrow -159,399 Less Arrow -178,686
EBITDA -304,677 More Arrow -150,188 Less Arrow -164,194
Total assets 662,024 Less Arrow 653,167 More Arrow 671,369
Current assets 467,710 More Arrow 485,749 More Arrow 547,107
Current liabilities 330,813 Less Arrow 223,774 Less Arrow 214,224
Equity capital 173,568 More Arrow 401,907 More Arrow 421,043
- share capital 6,770 Less Arrow 5,832 Less Arrow 5,475
Employees (average) 89 Less Arrow 68 Less Arrow 50

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 26.2% More Arrow 61.5% More Arrow 62.7%
Turnover per employee 2,717 Less Arrow 802 Less Arrow 0
Profit as a percentage of turnover -134.9% Less Arrow -292.5%
Return on assets (ROA) -46.4% More Arrow -24.1% Less Arrow -26.2%
Current ratio 141.4% More Arrow 217.1% More Arrow 255.4%
Return on equity (ROE) -188.0% More Arrow -39.7% Less Arrow -42.4%
Change turnover 183,471 Less Arrow 54,502 Less Arrow 0
Change turnover % 314%
Chg. No. of employees 21 Less Arrow 18 Less Arrow 11
Chg. No. of employees % 31% More Arrow 36% Less Arrow 28%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.